angioG Cancer Research Results

angioG, angiogenesis: Click to Expand ⟱
Source:
Type:
Process through which new blood vessels.
Angiogenesis, the process of new blood vessel formation from pre-existing vessels, plays a crucial role in cancer progression and metastasis. Tumors require a blood supply to grow beyond a certain size and to spread to other parts of the body.
Vascular Endothelial Growth Factor (VEGF): VEGF is one of the most important pro-angiogenic factors. It stimulates endothelial cell proliferation and migration, leading to the formation of new blood vessels. Many tumors overexpress VEGF, which correlates with poor prognosis.
Hypoxia-Inducible Factor (HIF): In response to low oxygen levels (hypoxia), tumors can activate HIF, which in turn promotes the expression of VEGF and other angiogenic factors. This mechanism allows tumors to adapt to their microenvironment and sustain growth.
-Tumour development and progression beyond a size of few millimetres‐cubed crucially depends on the onset of angiogenesis, that is, the ‘angiogenic switch’


Scientific Papers found: Click to Expand⟱
524- MF,    Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs)
- vitro+vivo, PC, MS-1 - vitro+vivo, PC, HUVECs
other↓, TumCP↓, TumCMig↓, VEGFR2/KDR/Flk1↓, TumVol↓, HSP70/HSPA5↓, HSP90↓, TumCCA↑, angioG↓,
525- MF,    Pulsed electromagnetic fields regulate metabolic reprogramming and mitochondrial fission in endothelial cells for angiogenesis
- in-vitro, Nor, HUVECs
*angioG↑, *GPx1↑, *GPx4↑, *SOD↑, *PFKM↑, *PFKL↑, *PKM2↑, *PFKP↑, *HK2↑, *GLUT1↑, *GLUT4↑, *ROS↓, *MMP↝, *Glycolysis↑, *OXPHOS↓,
509- MF,    Is extremely low frequency pulsed electromagnetic fields applicable to gliomas? A literature review of the underlying mechanisms and application of extremely low frequency pulsed electromagnetic fields
- Review, GBM, NA
Ca+2↑, TumAuto↑, Apoptosis↑, angioG↓, ROS↑,
499- MF,    The Effect of Pulsed Electromagnetic Fields on Angiogenesis
- Review, Var, NA
*angioG↑, *VEGF↑, *VGCC↑,
3497- MFrot,  MF,    The Effect of a Rotating Magnetic Field on the Regenerative Potential of Platelets
- Human, Nor, NA
*PDGFR-BB↑, *TGF-β↑, *IGF-1↑, *FGF↑, *angioG↑, *Inflam↓, *ROS↓,
9081- MGF,    Anti-angiogenic effects of mangiferin and mechanism of action in metastatic melanoma
- in-vitro, Melanoma, NA
Inflam↓, lipid-P↓, NF-kB↓, IL6↓, TNF-α↓, IFN-γ↓, VEGF↓, uPA↓, MCP1/CCL2↓, PGF↓, angioG↓,
9087- MGF,    Mangiferin in human disease: Multifaceted mechanisms and applications (Review)
- Review, Var, NA
TumCP↓, TumCI↓, angioG↓, *BioAv↓, *neuroP↑, *Inflam↓, *AntiCan↑, *ROS↓, *BioAv↑, *BioAv↝, *Half-Life↝, *BBB↓, CDK1↑, CycB/CCNB1↑, Bcl-2↓, BAX↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, cl‑PARP↑, PI3K↓, Akt↓, mTOR↓, MMP↓, MOMP↑, Apoptosis↑, lipid-P↑, TCA↓, NRF2↑, NQO1↑, ROS↓, RadioS↑,
1779- MLT,    Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
- Review, BC, NA
QoL↑, OS↑, Dose∅, antiOx↑, ROS↑, SOD↑, Catalase↑, GPx↑, Risk↓, NK cell↑, IL1β↓, IL6↓, TNF-α↓, radioP↑, chemoP↑, TumVol↓, TumMeta↓, angioG↓, ChemoSen↑, eff↑,
8669- MLT,    Melatonin in lung cancer: integrating molecular mechanisms, tumor microenvironment regulation, apoptotic signaling, and therapeutic opportunities
- Review, Lung, NA
Apoptosis↑, ROS↑, Cyt‑c↑, Bcl-2↓, Casp↑, TumCP↓, TumCI↓, angioG↓, Inflam↓, ChemoSen↑, RadioS↑,
8671- MLT,    Targeting mitochondrial metabolism in renal cell carcinoma with melatonin: Preclinical evidence and clinical perspectives
- Review, RCC, NA
OXPHOS↑, Warburg↓, ROS↑, Akt↓, mTOR↓, NF-kB↓, HIF-1↓, VEGF↓, MAPK↓, TumCG↓, angioG↓, TumCI↓, Apoptosis↑, TumAuto↑, Synergy↑, *toxicity↓,
8692- MLT,    Melatonin as a Radio-Sensitizer in Cancer
- Review, Var, NA
RadioS↑, radioP↑, ROS↑, DNArepair↓, angioG↓, Inflam↓, Apoptosis↑, Telomerase↓, HSP70/HSPA5↑, P53↑, Glycolysis↓, Dose?, OS∅,
8673- MLT,    Therapeutic Potential of Melatonin in Gastrointestinal Cancers: Molecular Mechanisms, Preclinical Evidence and Clinical Implications
- Review, GC, NA
ChemoSen↑, TumVol↓, β-catenin/ZEB1↓, Risk↓, radioP↑, Mucositis↓, Dose↝, toxicity↓, BioAv↓, *antiOx↑, *SOD↑, *GPx↑, *Catalase↑, *NRF2↑, Apoptosis↑, Estro↝, Telomerase↓, *ROS↓, angioG↓, Imm↑, TumCCA↑, Glycolysis↓, OXPHOS↑, mTORC1↓, VEGF↓, Hif1a↓, ROS↓, TumAuto↓, HSP70/HSPA5↓, PI3K↓, Akt↓, mTOR↓, BAX↑, Casp↑, Cyt‑c↑, tumCV↓, TumCMig↓, TumCI↓, TumVol↓, TumW↓, P21↑, P53↑, Synergy↑, ER Stress↑, Synergy↑, RadioS↑, eff↑, eff↑, fatigue↓, Sleep↑,
8618- MO,    Lemon Balm Extracts Prevent Breast Cancer Progression In Vitro and In Ovo on Chorioallantoic Membrane Assay
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
tumCV↓, selectivity?, Ingr↝, Dose↝, eff?, angioG↓, chemoPv↑,
8799- MT/VAE,    Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity
- vitro+vivo, Lung, EAhy926
angioG↓,
7342- MT/VAE,  Hne,    Minor regression and long-time survival (56 months) in a patient with malignant pleural mesothelioma under Viscum album and Helleborus niger extracts—a case report
- Case Report, MM, NA
angioG↓, TumVol↓, QoL↑, OS↑, Dose↝,
8966- mushLions,    Hericium erinaceus Inhibits TNF-α-Induced Angiogenesis and ROS Generation through Suppression of MMP-9/NF-κB Signaling and Activation of Nrf2-Mediated Antioxidant Genes in Human EA.hy926 Endothelial Cells
- in-vitro, Lung, EAhy926
TumCMig↓, TumCI↓, MMP9↓, ICAM-1↓, NF-kB↓, IκB↓, ROS↓, HO-1↑, GCLC↑, NRF2↑, angioG↓, Inflam↓, TumCP↓,
8967- mushLions,    Recent developments in mushrooms as anti-cancer therapeutics: a review
- Review, Var, NA
ChemoSen↑, cFLIP↓, JNK↑, NF-kB↓, TumW↓, VEGF↓, COX2/PTGS2↓, 5LO↓, angioG↓, Ingr↝,
1798- NarG,    Naringenin: A potential flavonoid phytochemical for cancer therapy
- Review, Var, NA
*Inflam↓, *antiOx↓, neuroP↑, hepatoP↑, AntiCan↑, Apoptosis↑, TumCCA↑, angioG↓, ROS↝, SOD↑, TGF-β↓, Treg lymp↓, IL1β↓, *BioAv↝, ChemoSen↑, cardioP↑,
1799- NarG,    Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics
- Review, BC, NA
TumCCA↑, BioAv↑, Half-Life∅, TNF-α↓, Casp8↑, BAX↑, Bak↑, EGF↓, mTOR↓, PI3K↓, ERK↓, Akt↓, NF-kB↓, VEGF↓, angioG↓, antiOx↑, EMT↓, OS↑, MAPK↓, ChemoSen↑, MMP9↓, MMP2↓, ROS↑, ROS↑, GSH↓, Casp3↑, ROS↑,
6775- Neem,  Nimb,    Therapeutics Role of Azadirachta indica (Neem) and Their Active Constituents in Diseases Prevention and Treatment
- Review, Nor, NA
*antiOx↑, P53↑, PTEN↑, NF-kB↓, PI3K↓, Akt↓, Bcl-2↓, VEGF↓, *Inflam↓, *COX2/PTGS2↓, *5LO↝, *Wound Healing↑, *Imm↑, *hepatoP↑, *AntiDiabetic↑, *neuroP↑, *AntiViral↑, *Bacteria↑, *AntiBio↑, *AntiFungal↑, cMyc↓, BAX↓, IAP1↓, IAP2/BIRC3↓, Bcl-xL↓, survivin↓, XIAP↓, angioG↓,
6492- Nimb,    Review on Molecular and Chemopreventive Potential of Nimbolide in Cancer
- Review, Var, NA
Apoptosis↑, TumCCA↑, TumCP↓, TumCI↓, angioG↓, TumMeta↓, PTEN↑, NF-kB↓, Wnt↓, β-catenin/ZEB1↓, IKKα↓, CXCR2↓, CXCR4↓, Bcl-2↓, COX2/PTGS2↓, MMP9↓, VEGF↓, TIMP2↑, chemoPv↑, ROS↑, DR4↑, P53↑, BAX↑, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, Mcl-1↓, XIAP↓, survivin↓, FasL↑, FADD↑, EGFR↓, MMPs↓,
6485- Nimb,    Limonoids from neem (Azadirachta indica A. Juss.) are potential anticancer drug candidates
- Review, Var, NA
TumCG↓, TumCP↓, Apoptosis↑, Inflam↓, angioG↓, DrugR↓,
6487- Nimb,    Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development
- Review, Var, NA
TumCP↓, Apoptosis↓, TumMeta↑, angioG↓, *antiOx↑, *eff↑, Apoptosis↑, MOMP↑, CDK1↓, TumCCA↑, MAPK↓, JAK2↓, STAT3↓, PI3K↓, Akt↓, TumCP↓, *NRF2↑, NF-kB↓, GSK‐3β↑, Wnt↓, β-catenin/ZEB1↓, chemoPv↑, Bcl-xL↓, Bcl-2↓, survivin↓, Cyt‑c↑, BAX↑, BID↑, cl‑Casp↑, P53↑, DR5↑, DR4↑, ROS↑, lipid-P↑, MDA↑, MMP2↓, MMP9↓, uPA↓, ICAM-1↓, CXCR4↓, CXCR2↓, angioG↓, BBB↑,
6493- Nimb,    Nimbolide, a Limonoid Triterpene, Inhibits Growth of Human Colorectal Cancer Xenografts by Suppressing the Proinflammatory Microenvironment
- in-vivo, CRC, HCT116 - vitro+vivo, CRC, HT29
TumCP↓, Apoptosis↑, NF-kB↓, IKKα↓, Bcl-2↓, Bcl-xL↓, survivin↓, Mcl-1↓, cMyc↓, cycD1/CCND1↓, MMP9↓, CXCR4↓, ICAM-1↓, VEGF↓, angioG↓, TumCG↓,
4970- Nimb,    Insights into Nimbolide molecular crosstalk and its anticancer properties
- Review, Var, NA
chemoPv↑, Apoptosis↑, TumCP↓, TumCD↑, TumMeta↓, angioG↓,
4971- Nimb,    Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal
- Review, Var, NA
TumCP↓, Apoptosis↓, TumCI↓, angioG↓, TumMeta↓, Inflam↓,
1229- OA,    Review of the Clinical Effect of Orlistat
- Review, Var, NA
NPC1L1↓, FASN↓, ER Stress↑, angioG↓, TumCG↓,
4628- OLE,    Effects of oleuropein on tumor cell growth and bone remodelling: Potential clinical implications for the prevention and treatment of malignant bone diseases
- in-vitro, Var, NA
chemoPv↑, TumCP↓, angioG↓, TumCI↓, TumMeta↓,
4646- OLEC,    Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology
- Review, Var, NA
BioAv↓, *Inflam↓, *antiOx↓, cMET↓, STAT3↓, TNF-α↓, COX2/PTGS2↓, EMT↓, angioG↓, *GutMicro↝, eff↑,
8449- OM,    Ethanolic extract of Origanum syriacum L. leaves exhibits potent anti-breast cancer potential and robust antioxidant properties
- in-vitro, BC, MDA-MB-231
antiOx↑, ROS↑, TumCP↓, TumCCA↑, p‑p38↑, P21↑, Ki-67↓, eff↓, Apoptosis↑, Casp3↑, STAT3↑, P53↑, TumCMig↓, TumCI↓, FAK↓, iNOS↓, angioG↓,
6766- Oreg,    Chemical Composition, Biological Activity, and Potential Uses of Oregano (Origanum vulgare L.) and Oregano Essential Oil
- Review, Nor, NA
*AntiBio↑, *other↝, *antiOx↑, *Inflam↓, angioG↓, AntiCan↑,
2028- PB,    Potential of Phenylbutyrate as Adjuvant Chemotherapy: An Overview of Cellular and Molecular Anticancer Mechanisms
- Review, Var, NA
HDAC↓, TumCCA↑, P21↑, Dose↝, Telomerase↓, IGFBP3↑, p‑p38↑, JNK↑, ERK↑, BAX↑, Casp3↑, Bcl-2↓, Cyt‑c↝, FAK↓, survivin↓, VEGF↓, angioG↓, DNArepair↓, TumMeta↓, HSP27↑, ASK1↑, ROS↑, eff↑, ER Stress↓, GRP78/BiP↓, CHOP/DDIT3↑, AR↓, other?,
3259- PBG,    Propolis and its therapeutic effects on renal diseases: A review
- Review, Nor, NA
*Inflam↓, *COX2/PTGS2↓, *ROS↓, *NO↓, *NF-kB↓, TumCP↓, angioG↓, VEGF↓, STAT↓, Hif1a↓, RenoP↑, TLR4↓, *MDA↓, *GSH↑, *SOD↑, *Catalase↑, *toxicity∅,
1676- PBG,    Use of Stingless Bee Propolis and Geopropolis against Cancer—A Literature Review of Preclinical Studies
- Review, Var, NA
ROS↑, MMP↓, Bcl-2↓, Synergy↑, tumCV↓, TumCCA↑, angioG↓, PAK1↓, HDAC1↓, HDAC2↓, P53↑, PCNA↓, cycD1/CCND1↓, cycE/CCNE↓, P21?, BAX↑, cl‑Casp3↑, cl‑PARP↑, ChemoSen↑,
1660- PBG,    Emerging Adjuvant Therapy for Cancer: Propolis and its Constituents
- Review, Var, NA
MMPs↓, angioG↓, TumMeta↓, TumCCA↑, Apoptosis↑, ChemoSideEff↓, eff∅, HDAC↓, PTEN↑, p‑PTEN↓, p‑Akt↓, Casp3↑, p‑ERK↑, p‑FAK↑, Dose?, Akt↓, GSK‐3β↓, FOXO3↓, ChemoSen↑, IL2↑, IL10↑, NF-kB↓, VEGF↓, mtDam↑, ER Stress↑, AST↓, ALAT↓, ALP↓, COX2/PTGS2↓, eff↑, Bax:Bcl2↑,
1664- PBG,    Anticancer Activity of Propolis and Its Compounds
- Review, Var, NA
Apoptosis↑, TumCMig↓, TumCCA↑, TumCP↓, angioG↓, P21↑, p27/CDKN1B↑, CDK1↓, p‑CDK1↓, cycA1/CCNA1↓, CycB/CCNB1↓, P70S6K↓, CLDN2↓, HK2↓, PFK↓, PKM2↓, LDHA↓, TLR4↓, H3↓, α-tubulin↓, ROS↑, Akt↓, GSK‐3β↓, FOXO3↓, NF-kB↓, cycD1/CCND1↓, MMP↓, ROS↑, i-Ca+2↑, lipid-P↑, ER Stress↑, UPR↑, PERK↑, eIF2α↑, GRP78/BiP↑, BAX↑, PUMA↑, ROS↑, MMP↓, Cyt‑c↑, cl‑Casp8↑, cl‑Casp8↑, cl‑Casp3↑, cl‑PARP↑, eff↑, eff↑, RadioS↑, ChemoSen↑, eff↑,
1663- PBG,    Propolis and Their Active Constituents for Chronic Diseases
- Review, Var, NA
NF-kB↓, Casp↓, Fas↓, DNAdam↑, Casp3↑, P53↝, MMP↝, ROS↑, mtDam↑, Dose?, angioG↓, TumCP↓, TumCMig↓, BAX↑, selectivity↑, MMP↓, LDH↓, IL6↓, IL1β↓, TNF-α↓,
2381- PBG,    Chinese Poplar Propolis Inhibits MDA-MB-231 Cell Proliferation in an Inflammatory Microenvironment by Targeting Enzymes of the Glycolytic Pathway
- in-vitro, BC, MDA-MB-231
TumCP↓, TumCMig↓, TumCI↓, angioG↓, TNF-α↓, IL1β↓, IL6↓, NLRP3↓, Glycolysis↓, HK2↓, PFK↓, PKM2↓, LDHA↓, ROS↑, MMP↓,
8986- PCorn,    Health Benefits of Purple Corn (Zea mays L.) Phenolic Compounds
- Review, Nor, NA
antiOx↑, Inflam↓, AntiCan↑, angioG↓, *Obesity↓, *AntiDiabetic↑, *cardioP↑,
4922- PEITC,    Phenethyl Isothiocyanate: A comprehensive review of anti-cancer mechanisms
- Review, Var, NA
Risk↓, AntiCan↑, TumCP↓, TumMeta↓, ChemoSen↑, *BioAv↑, *other↝, *Dose↝, Dose↓, *BioAv↑, *Dose↝, *Half-Life↝, *toxicity↝, GSH↓, ROS↑, CYP1A1↑, CYP1A2↑, P450↓, CYP2E1↑, CYP3A4↓, CYP2A3/CYP2A6↓, *ROS↓, *GPx1↑, *SOD1↑, *SOD2↑, Akt↓, EGFR↓, HER2/EBBR2↓, P53↑, Telomerase↓, selectivity↑, MMP↓, Cyt‑c↑, Apoptosis↑, DR4↑, Fas↑, XIAP↓, survivin↓, TumAuto↑, Hif1a↓, angioG↓, MMPs↓, ERK↓, NF-kB↓, EMT↓, TumCI↓, TumCMig↓, Glycolysis↓, ATP↓, selectivity↑, *antiOx↑, Dose↝, other↝, OCR↓, GSH↓, ITGB1↓, ITGB6↓, ChemoSen↑,
4918- PEITC,    Nutritional Sources and Anticancer Potential of Phenethyl Isothiocyanate: Molecular Mechanisms and Therapeutic Insights
- Review, Var, NA
Apoptosis↑, TumCP↓, angioG↓, TumMeta↓, NF-kB↓, Akt↓, MAPK↓, *BioAv↓, ROS↑, lipid-P↑, AIF↑, Cyt‑c↑, DR4↑, DR5↑, TumCCA↑, JAK↓, STAT3↓, MMP2↓, MMP9↓, PKCδ↓, Hif1a↓, JNK↓, Mcl-1↓, COX2/PTGS2↓, MMP↓, Casp3↑, ChemoSen↑, *BioAv↓, Half-Life↓,
4932- PEITC,    Pharmacokinetics and Pharmacodynamics of Phenethyl Isothiocyanate: Implications in Breast Cancer Prevention
- Review, BC, NA
TumCCA↑, ROS↑, GSH↓, ERα/ESR1↓, TumMeta↓, angioG↓,
4939- PEITC,    Phenethyl Isothiocyanate Inhibits Angiogenesis In vitro and Ex vivo
- in-vitro, Pca, PC3 - ex-vivo, Nor, HUVECs
Risk↓, angioG↓, VEGF↓, TumCMig↓, Akt↓, EGF↓, TumCMig↓,
9017- Phyco,    Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7
eff↑, TumCP↓, Tumccf↓, TumCCA↑, cycE/CCNE↓, CDK2↓, P21↑, Apoptosis↑, γH2AX↑, Bax:Bcl2↑, Cyt‑c↑, Casp9↑, TumCMig↓, TumCA↑, angioG↓, COX2/PTGS2↓, PGE2↓, MAPK↓, toxicity↓,
9012- Phyco,    Phycocyanin from Arthrospira platensis as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies
- Review, Var, NA
*Ingr↝, *antiOx↑, *Inflam↓, Imm↑, AntiCan↑, *toxicity↓, *Dose↝, *GutMicro↑, *IBI↑, Apoptosis↑, TumCCA↑, DNArepair↓, ROS↑, Cyt‑c↑, BAX↑, cl‑PARP1↑, CellShr↑, TumCMig↓, COX2/PTGS2↓, E-cadherin↑, MMP2↓, MMP9↓, HIF-1↓, angioG↓, MCP1/CCL2↓, MIP-1β↑, Ca+2↑, Cal9↑, Wnt↓, β-catenin/ZEB1↓, PPARα↑, PPARγ↑, eff↝, Half-Life↓, Synergy↑, ChemoSen↑, chemoP↑, EMT↓, N-cadherin↓, E-cadherin↑, TumCMig↓, TumCI↓, selectivity↑,
3587- PI,    Piperine: A review of its biological effects
- Review, Park, NA - Review, AD, NA
*hepatoP↑, *Inflam↓, *neuroP↑, *antiOx↑, *angioG↑, *cardioP↑, *BioAv↑, *P450↓, *Synergy↑, *BioEnh↑, E-cadherin↓, ER(estro)↓, MMP2↓, MMP9↓, VEGF↓, cMyc↓, BAX↑, P53↑, TumCG↓, OS↑, *cognitive↑, *GSK‐3β↓, *GSH↑, *Casp3↓, *Casp9↓, *Cyt‑c↓, *lipid-P↓, *motorD↑, *AChE↓, *memory↑, *cardioP↑, *ROS↓, *PPARγ↑, *ALAT↓, *AST↓, *ALP↓, *AMPK↑, *5HT↑, *SIRT1↑, *eff↑, *antiAll↑,
1256- PI,    Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models
- in-vitro, adrenal, PHEO - in-vivo, NA, NA
Apoptosis↑, ROS↑, TumCMig↓, TumCI↓, EMT↓, angioG↓, Necroptosis↑, MAPK↑, ERK↑,
2999- PL,    Piperlongumine alleviates corneal allograft rejection via suppressing angiogenesis and inflammation
- in-vivo, Nor, HUVECs
*Inflam↓, *angioG↓, *Hif1a↓, *VEGF↓, *ICAM-1↓, *VCAM-1↓, *neuroP↑,
2946- PL,    Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
- Review, Var, NA
ROS↑, GSH↓, DNAdam↑, ChemoSen↑, RadioS↑, BioEnh↑, selectivity↑, BioAv↓, eff↑, p‑Akt↓, mTOR↓, GSK‐3β↓, β-catenin/ZEB1↓, HK2↓, Glycolysis↓, Cyt‑c↑, Casp9↑, Casp3↑, Casp7↑, cl‑PARP↑, TrxR↓, ER Stress↑, ATF4↝, CHOP/DDIT3↑, Prx4↑, NF-kB↓, cycD1/CCND1↓, CDK4↓, CDK6↓, p‑RB1↓, RAS↓, cMyc↓, TumCCA↑, selectivity↑, STAT3↓, NRF2↑, HO-1↑, PTEN↑, P-gp/ABCB1↓, MDR1↓, MRP1/ABCC1↓, survivin↓, Twist↓, AP-1↓, Sp1/3/4↓, STAT1↓, STAT6↓, SOX4↑, XBP-1↑, P21↑, eff↑, Inflam↓, COX2/PTGS2↓, IL6↓, MMP9↓, TumMeta↓, TumCI↓, ICAM-1↓, CXCR4↓, VEGF↓, angioG↓, Half-Life↝, BioAv↑,
2948- PL,    The promising potential of piperlongumine as an emerging therapeutics for cancer
- Review, Var, NA
tumCV↓, TumCP↓, TumCI↓, angioG↓, EMT↓, TumMeta↓, *hepatoP↑, *lipid-P↓, *GSH↑, cardioP↑, CycB/CCNB1↓, cycD1/CCND1↓, CDK2↓, CDK1↓, CDK4↓, CDK6↓, PCNA↓, Akt↓, mTOR↓, Glycolysis↓, NF-kB↓, IKKα↓, JAK1↓, JAK2↓, STAT3↓, ERK↓, cFos↓, Slug↓, E-cadherin↑, TOP2↓, P53↑, P21↑, Bcl-2↓, BAX↑, Casp3↑, Casp7↑, Casp8↑, p‑HER2/EBBR2↓, HO-1↑, NRF2↑, BIM↑, p‑FOXO3↓, Sp1/3/4↓, cMyc↓, EGFR↓, survivin↓, cMET↓, NQO1↑, SOD2↑, TrxR↓, MDM2↓, p‑eIF2α↑, ATF4↑, CHOP/DDIT3↑, MDA↑, Ki-67↓, MMP9↓, Twist↓, SOX2↓, Nanog↓, OCT4↓, N-cadherin↓, Vim↓, Snail↓, TumW↓, TumCG↓, HK2↓, RB1↓, IL6↓, IL8↓, SOD1↑, RadioS↑, ChemoSen↑, toxicity↓, Sp1/3/4↓, GSH↓, SOD↑,

Showing Research Papers: 351 to 400 of 492
Prev Page 8 of 10 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 492

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 17,   antiOx⇅, 1,   ARE↓, 1,   Catalase↓, 2,   Catalase↑, 4,   Copper↓, 2,   Fenton↑, 4,   frataxin↑, 1,   GCLC↑, 1,   GPx↑, 4,   GPx4↓, 4,   GSH↓, 28,   GSH↑, 3,   GSH⇅, 1,   GSH/GSSG↓, 1,   GSR↓, 1,   ox-GSSG↑, 1,   GSTs↓, 1,   H2O2↓, 1,   H2O2↑, 4,   HO-1↓, 6,   HO-1↑, 11,   HO-2↓, 1,   Iron↑, 2,   Iron∅, 1,   Keap1↓, 2,   lipid-P?, 1,   lipid-P↓, 4,   lipid-P↑, 16,   MDA↓, 5,   MDA↑, 2,   NOX↓, 1,   NQO1↑, 2,   NRF2↓, 17,   NRF2↑, 20,   Prx↓, 2,   Prx4↑, 1,   PrxI↓, 1,   PrxII↓, 1,   PYCR1↓, 1,   RNS↑, 1,   ROS?, 1,   ROS↓, 23,   ROS↑, 181,   ROS⇅, 4,   ROS↝, 5,   i-ROS↑, 1,   mt-ROS↑, 5,   SOD↓, 6,   SOD↑, 7,   SOD1↓, 2,   SOD1↑, 1,   SOD2↑, 2,   TAC↑, 1,   TBARS↑, 1,   Thiols↓, 3,   Trx↓, 2,   ox-Trx1↑, 1,   TrxR↓, 6,   TrxR1↓, 2,   xCT/SLC7A11↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

ATOX1↝, 1,   Ferritin↓, 2,   IronCh↑, 2,   NCOA4↑, 1,   Tf↓, 2,   Tf↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   BCR-ABL↓, 1,   CDC2↓, 3,   CDC25↓, 7,   compI↓, 3,   compII↓, 2,   compIII↓, 2,   EGF↓, 5,   ETC↓, 5,   HSP60/HSPD1↓, 2,   mitResp↓, 2,   Mortalin↓, 1,   mtDam↓, 1,   mtDam↑, 19,   OCR↓, 5,   OCR↑, 2,   OXPHOS↓, 4,   OXPHOS↑, 3,   PDH↓, 2,   PINK1↑, 1,   SDH↓, 1,   SIRT3↓, 1,   VDAC1↓, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   5LO↓, 4,   AApath↓, 1,   ACC↓, 1,   ACC↑, 1,   ACC-α↓, 1,   ACC1↓, 1,   ACLY↓, 1,   ALAT↓, 3,   AMP↓, 1,   AMPK↓, 1,   AMPK↑, 18,   p‑AMPK↑, 1,   p‑AMT/GCST/T-protein↑, 1,   ARG↓, 1,   ATP↓, 15,   mt-ATP↓, 2,   CAIX/CA9↓, 1,   CBS↑, 1,   citrate↓, 1,   CPT1A↓, 1,   CYP4A/CYP4A11/CYP4A22↓, 1,   ECAR↓, 2,   ECAR↝, 1,   ENO1↓, 1,   FABP5/E-FABP↓, 1,   FASN↓, 6,   FASN↑, 1,   GAPDH↓, 1,   GlucoseCon↓, 3,   Glycolysis↓, 32,   GSK‐3β↓, 11,   GSK‐3β↑, 3,   p‑GSK‐3β↓, 4,   Histones↑, 1,   HK2↓, 12,   HMG-CoA↓, 2,   lactateProd↓, 5,   LDHA↓, 4,   LDL↓, 3,   LDL↑, 1,   lipoGen↓, 1,   NADPH↓, 4,   NADPH↑, 2,   NPC1L1↓, 2,   O-Glc↓, 1,   PCK1↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 8,   p‑PDK1 / PDPK1↓, 1,   PDK3↑, 1,   PDKs↓, 1,   PFK↓, 2,   PFK1↓, 1,   PFK2?, 1,   PKM2↓, 9,   PKM2↑, 1,   PKM2:PKM1↓, 1,   SIRT1↓, 8,   SIRT1↑, 9,   SIRT2↓, 1,   SREBP1/SREBF1↓, 2,   SREBP2↓, 1,   TCA↓, 3,   Warburg↓, 6,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 6,   APAF1↑, 6,   Apoptosis?, 1,   Apoptosis↓, 6,   Apoptosis↑, 194,   mt-Apoptosis↑, 3,   ASK1↑, 1,   BAD↓, 2,   BAD↑, 4,   Bak↑, 12,   BAX↓, 3,   BAX↑, 76,   BAX⇅, 1,   Bax:Bcl2↑, 23,   Bcl-2↓, 82,   Bcl-2↑, 2,   Bcl-xL↓, 28,   BID↓, 1,   BID↑, 3,   BIM↓, 1,   BIM↑, 5,   BNIP3↝, 1,   BOK↑, 1,   Casp↓, 2,   Casp↑, 35,   Casp↝, 1,   cl‑Casp↑, 1,   Casp10↑, 1,   Casp12?, 1,   Casp12↑, 1,   cl‑Casp12↑, 1,   Casp2↑, 1,   Casp3?, 1,   Casp3↓, 4,   Casp3↑, 99,   cl‑Casp3↑, 12,   proCasp3↑, 2,   Casp6↓, 1,   Casp6↑, 1,   Casp7↑, 17,   Casp8↓, 1,   Casp8↑, 24,   Casp8∅, 1,   cl‑Casp8↑, 3,   proCasp8↑, 1,   pro‑Casp8↑, 1,   Casp9↓, 1,   Casp9↑, 65,   cl‑Casp9↑, 7,   CellShr↑, 2,   cFLIP↓, 3,   Cupro↑, 2,   Cyt‑c↑, 69,   Cyt‑c↝, 2,   Diablo↑, 8,   DR5↑, 22,   FADD↑, 8,   Fas↓, 2,   Fas↑, 18,   FasL↑, 7,   Ferroptosis↑, 12,   GSDME↑, 1,   IAP1↓, 8,   IAP2/BIRC3↓, 5,   ICAD↓, 1,   ICD↑, 1,   iNOS↓, 11,   Mcl-1?, 1,   Mcl-1↓, 29,   MDM2↓, 10,   MDM2↑, 1,   p‑MDM2↓, 1,   MOMP↓, 1,   MOMP↑, 7,   NAIP↓, 1,   Necroptosis↑, 4,   necrosis↑, 3,   NOXA↑, 4,   p38↓, 1,   p38↑, 13,   p‑p38↓, 3,   p‑p38↑, 2,   Paraptosis↑, 2,   PUMA↑, 6,   Pyro↑, 3,   RIP3↑, 1,   survivin↓, 55,   TNFR 1↑, 2,   TRAIL↑, 2,   TRAIL⇅, 1,   TRAILR↑, 2,   TumCD↑, 17,   XIAP↓, 29,   YAP/TEAD↓, 7,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 126,   Akt↑, 8,   Akt↝, 1,   Akt∅, 1,   p‑Akt↓, 27,   AKT1↓, 3,   Akt2↓, 1,   BRAF↓, 1,   CK2↓, 3,   cMET↓, 3,   p‑cMET↑, 1,   CREB↓, 1,   CREB2↓, 1,   cSrc↓, 1,   DDIT4↑, 1,   DYRK1B↓, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERK↓, 36,   ERK↑, 8,   ERK↝, 2,   ERK∅, 1,   p‑ERK↓, 9,   p‑ERK↑, 1,   FGFR1↓, 2,   FOXD3↑, 2,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   Hippo↓, 1,   Hippo↝, 1,   IGF-1R↓, 3,   IGFR↓, 1,   IKKα↓, 6,   p‑IKKα↓, 1,   ILK↓, 1,   IκB↓, 2,   IκB↑, 1,   p‑IκB↓, 1,   JAK↓, 5,   JAK1↓, 4,   JAK1↑, 1,   JAK2↓, 11,   JNK↓, 3,   JNK↑, 14,   JNK↝, 1,   p‑JNK↓, 2,   LIMK1↓, 1,   MAPK↓, 35,   MAPK↑, 11,   MAPK↝, 1,   MEK↓, 5,   mTOR↓, 77,   mTOR↑, 1,   p‑mTOR↓, 3,   mTORC2↓, 2,   mTORC2↑, 1,   p70S6↓, 1,   p‑p70S6↓, 1,   P70S6K↓, 5,   p‑P70S6K↓, 1,   P90RSK↓, 1,   PDGFR-BB↓, 1,   p‑PDGFR-BB↓, 1,   PDGFRB↓, 1,   PI3K↓, 92,   PI3K↑, 1,   PI3K↝, 1,   p‑PI3K↓, 2,   PI3K/Akt↓, 1,   p‑PI3k/Akt/mTOR↓, 1,   PKCδ↓, 11,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↓, 2,   PTEN↑, 24,   p‑PTEN↓, 1,   Raf↓, 3,   RAS↓, 10,   RIP1↑, 1,   SHP1↑, 1,   Sp1/3/4↓, 16,   STAT↓, 3,   STAT3↓, 61,   STAT3↑, 2,   STAT3↝, 1,   p‑STAT3↓, 9,   p‑STAT3↑, 2,   STAT5↓, 1,   STAT6↓, 3,   THEM4/CTMP↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF2↓, 1,   ATF3↑, 1,   ATF4↓, 1,   ATF4↑, 3,   ATF4↝, 1,   CBP↓, 2,   cJun↓, 3,   cJun↑, 2,   cMyc↓, 35,   cMyc↑, 1,   p‑cMyc↑, 1,   DNMT1↓, 6,   DNMT3A↓, 2,   DNMT3B↓, 2,   DNMTs↓, 7,   EZH2↓, 1,   FOXM1↓, 4,   FOXO↑, 1,   FOXO1↓, 2,   FOXO1↑, 1,   FOXO3↓, 5,   FOXO3↑, 6,   FOXO3↝, 1,   p‑FOXO3↓, 2,   H3↓, 2,   p‑H3↓, 1,   ac‑H3↑, 1,   H4↑, 1,   ac‑H4↑, 1,   HATs↓, 6,   HATs↑, 2,   HDAC↓, 24,   HDAC1↓, 7,   HDAC2↓, 1,   HDAC3↓, 1,   HDAC4↓, 2,   HDAC6↓, 1,   HDAC8↓, 2,   HES1↓, 2,   miR-106b↓, 1,   miR-107↑, 1,   miR-139-5p↑, 1,   miR-140↑, 1,   miR-155↓, 1,   miR-194↑, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-203↑, 1,   miR-205↑, 1,   miR-21↓, 6,   miR-21↑, 1,   miR-218↑, 1,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-29b↓, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   miR-339-5p↝, 1,   miR-340↓, 1,   miR-34a↑, 2,   miR-34b-5p↑, 1,   miR-375↑, 1,   miR-384↑, 1,   miR-422a↑, 1,   Myc↓, 5,   MYCN↓, 1,   NDRG1↑, 1,   NEAT1↓, 1,   OCT4↓, 9,   other?, 1,   other↓, 4,   other↑, 4,   other⇅, 1,   other↝, 14,   SOX2↓, 3,   SOX4↓, 1,   SOX4↑, 1,   SOX9↓, 1,   SUV39H↓, 2,   TFE3↑, 1,   tumCV↓, 29,   tumCV↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 1,   CHOP/DDIT3↑, 17,   COX17↝, 1,   CUL1↝, 1,   CUL5↝, 1,   eIF2α↓, 1,   eIF2α↑, 2,   p‑eIF2α↑, 3,   ER Stress↓, 2,   ER Stress↑, 35,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 9,   HSP27↓, 2,   HSP27↑, 1,   HSP27↝, 1,   HSP70/HSPA5↓, 6,   HSP70/HSPA5↑, 1,   HSP70/HSPA5↝, 1,   HSP90↓, 16,   HSP90↑, 1,   HTRA↓, 2,   PERK↑, 6,   Proteasome↓, 1,   SERPINH1/HSP47↓, 1,   UPR↑, 4,   XBP-1↓, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 2,   ATG5↑, 4,   ATG7↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 10,   CTSB↓, 1,   CTSD↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 2,   LC3B↓, 1,   LC3B-II↑, 3,   LC3II↑, 10,   LC3s↑, 1,   p62↓, 4,   p62↑, 3,   p‑p62↑, 1,   PARK2↑, 1,   RUBCN↓, 1,   SESN2↑, 2,   TumAuto↓, 2,   TumAuto↑, 47,   TumAuto⇅, 1,   TumAuto↝, 1,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 3,   BRCA1↓, 3,   BRCA1↑, 2,   BRCA1↝, 1,   BRCA2↓, 1,   DFF45↓, 1,   DFF45↑, 2,   DNAdam↓, 3,   DNAdam↑, 50,   DNAdam⇅, 1,   DNArepair↓, 6,   DNArepair↑, 1,   m-FAM72A↓, 1,   G9a↓, 1,   hTERT/TERT↓, 11,   MGMT↓, 1,   p16↑, 2,   P53?, 1,   P53↑, 66,   P53↝, 3,   p‑P53↑, 2,   PARP↓, 1,   PARP↑, 16,   cl‑PARP↓, 2,   cl‑PARP↑, 53,   PARP1↑, 1,   cl‑PARP1↑, 1,   PCNA↓, 21,   SIRT6↓, 1,   SIRT6↑, 1,   Telomerase↓, 16,   TOP1↓, 8,   TOP2↓, 6,   TOP2↑, 1,   TP53↑, 3,   TRF2↓, 1,   UHRF1↓, 1,   γH2AX↑, 4,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 11,   CDK1↑, 3,   p‑CDK1↓, 2,   CDK2↓, 32,   CDK2↑, 2,   CDK4↓, 35,   CDK4↑, 2,   CDK4/6↓, 1,   CDK6↓, 18,   CDK6↑, 2,   CDK7↓, 1,   CDK8↓, 1,   CHK1↓, 1,   CHK1↑, 2,   Chk2↓, 1,   Chk2↑, 2,   ChrCon↑, 1,   Cyc↓, 3,   cycA1/CCNA1↓, 7,   CycB/CCNB1↓, 20,   CycB/CCNB1↑, 2,   cycD1/CCND1↓, 56,   CycD3↓, 3,   cycE/CCNE↓, 21,   cycE1↓, 1,   E2Fs↓, 5,   E2Fs↑, 1,   GADD45A↓, 1,   Ki-67↓, 23,   mitA↓, 1,   mitA↑, 1,   p19↑, 1,   P21?, 1,   P21↓, 3,   P21↑, 44,   p27/CDKN1B↑, 19,   pRB↑, 1,   p‑pRB↓, 1,   RB1↓, 1,   RB1↑, 2,   p‑RB1↓, 5,   Securin↓, 1,   TubPol↓, 1,   TumCCA?, 1,   TumCCA↓, 7,   TumCCA↑, 167,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 3,   p‑4E-BP1↓, 1,   ALDH↓, 8,   ALDH1A1↓, 1,   Axin2↑, 1,   BMI1↓, 1,   BMPs↑, 2,   CD133↓, 4,   CD133↑, 1,   CD24↓, 1,   CD34↓, 1,   cFos↓, 6,   cMYB↓, 2,   CSCs?, 1,   CSCs↓, 48,   CSCs↑, 2,   Diff↑, 4,   FGF↓, 2,   FGF↑, 1,   Gli↓, 1,   Gli1↓, 5,   HH↓, 11,   HH∅, 1,   HMGCR↓, 1,   IGF-1↓, 10,   IGF-2↓, 1,   IGFBP3↑, 4,   Jun↓, 1,   Ki-67↓, 23,   Let-7↑, 2,   mTORC1↓, 5,   Nanog↓, 7,   Nestin↓, 1,   NICD↓, 1,   NOTCH↓, 12,   NOTCH↑, 1,   NOTCH1↓, 8,   NOTCH1↑, 3,   OGF↑, 1,   OGFr↑, 1,   p300↓, 2,   PTCH1↓, 1,   PTCH2↓, 1,   SCF↓, 1,   Shh↓, 4,   Smo↓, 3,   STAT1↓, 1,   TAZ↓, 1,   TumCG↓, 92,   TumCG↑, 1,   TumCP↓, 158,   TumCP↑, 6,   tyrosinase↓, 1,   Wnt↓, 37,   Wnt/(β-catenin)↓, 2,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   annexin II↓, 1,   AntiAg?, 1,   AP-1↓, 8,   ARG1/2↑, 1,   ASAP2↓, 1,   AXL↓, 1,   CA↓, 3,   Ca+2↓, 3,   Ca+2↑, 26,   Ca+2↝, 5,   i-Ca+2↑, 1,   CAFs/TAFs↓, 1,   cal2↓, 1,   Cal9↑, 1,   CCN2/CTGF↓, 1,   Cdc42↓, 1,   Cdc42↑, 1,   Chl↓, 1,   Cofilin↓, 1,   COL1↓, 3,   COL3A1↓, 1,   COL4A3↓, 1,   E-cadherin↓, 5,   E-cadherin↑, 34,   EM↑, 1,   EMT↓, 69,   EMT↑, 2,   EpCAM↓, 3,   F-actin↓, 1,   FAK↓, 18,   p‑FAK↓, 4,   p‑FAK↑, 1,   Fibronectin↓, 3,   GLI2↓, 1,   GLI3↓, 1,   IQGAP3↓, 1,   ITGB1↓, 2,   ITGB3↓, 3,   ITGB6↓, 1,   KRAS↓, 1,   LEF1↓, 1,   MALAT1↓, 2,   MET↓, 1,   MMP-10↓, 2,   MMP1↓, 9,   MMP13↓, 3,   MMP14↓, 1,   MMP16↓, 2,   MMP2?, 1,   MMP2↓, 77,   MMP3↓, 9,   MMP7↓, 9,   MMP9?, 1,   MMP9↓, 97,   MMP9↑, 2,   MMPs↓, 40,   MUC4↓, 2,   N-cadherin↓, 20,   NEDD9↓, 1,   p‑p44↓, 1,   PAK1↓, 1,   PAK1↑, 1,   pax↓, 1,   PDGF↓, 10,   PGF↓, 1,   Rac1↓, 3,   RECK↑, 3,   Rho↓, 5,   Rho↑, 1,   ROCK1↓, 4,   ROCK1↑, 1,   Slug↓, 11,   Smad1↓, 2,   Smad1↝, 1,   p‑SMAD2↓, 1,   SMAD3↓, 2,   p‑SMAD3↓, 1,   Snail?, 1,   Snail↓, 18,   STAC2↓, 1,   TET1↑, 2,   TGF-β↓, 18,   TGF-β↑, 1,   TGF-β↝, 1,   TGF-β1↓, 2,   TIMP1↑, 10,   TIMP2↓, 1,   TIMP2↑, 13,   TIMP3↑, 1,   TRIB3↑, 1,   TSC1↑, 1,   TSP-1↑, 9,   TumCA↓, 1,   TumCA↑, 1,   TumCI↓, 109,   TumCI↑, 1,   TumCMig↓, 82,   TumCMig↑, 3,   TumMeta?, 1,   TumMeta↓, 126,   TumMeta↑, 7,   Twist↓, 18,   TXNIP↑, 1,   uPA↓, 20,   uPAR↓, 3,   Vim↓, 26,   Zeb1↓, 8,   ZEB2↓, 2,   α-SMA↓, 3,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 41,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 449,   angioG↑, 11,   angioG∅, 1,   angioS↑, 1,   CD31/PECAM-1↓, 12,   EGR1↑, 1,   Endoglin↓, 1,   Endoglin↑, 1,   eNOS↓, 3,   HIF-1↓, 11,   Hif1a↓, 83,   Hif1a↑, 1,   Hif1a↝, 1,   Hypoxia↓, 1,   LymphAG↓, 1,   NO↓, 3,   NO↑, 1,   TYMP/ECGF1↓, 1,   VCAM-1↓, 3,   VEGF↓, 183,   VEGF↑, 2,   VEGFR1↓, 5,   VEGFR2/KDR/Flk1↓, 32,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↑, 9,   CLDN1↓, 2,   CLDN1↑, 1,   CLDN2↓, 1,   CTR1↝, 1,   CX43/GJA1↓, 1,   EPR↑, 10,   GLUT1↓, 12,   GLUT2↓, 1,   GLUT4↓, 1,   IBI↑, 1,   MMP↓, 81,   MMP↑, 2,   MMP↝, 1,   MPT↑, 5,   NHE1↓, 2,   OCLN↑, 1,   TJ↑, 1,   TRPV1↑, 2,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 1,   CD4+↓, 1,   CD44↓, 15,   CD8+↑, 1,   COX1↓, 2,   COX2/PTGS2↓, 71,   COX2/PTGS2↑, 2,   CXCL16↓, 1,   CXCL6/GCP-2↓, 1,   CXCR2↓, 2,   CXCR4↓, 16,   DCells↑, 1,   DR4↑, 9,   Eos↑, 1,   Gal-3↓, 2,   GM-CSF↓, 3,   HLA-I/II↑, 1,   ICAM-1↓, 9,   IFN-γ↓, 3,   IFN-γ↑, 3,   Igs↑, 1,   IL1↓, 6,   IL10↓, 4,   IL10↑, 2,   IL12↓, 1,   IL12↑, 1,   IL1α↓, 1,   IL1β↓, 15,   IL2↓, 2,   IL2↑, 5,   IL4↓, 2,   IL4↑, 1,   IL6↓, 34,   IL8↓, 9,   Imm↑, 26,   Imm↝, 6,   INF-γ↑, 1,   Inflam↓, 51,   Inflam↝, 1,   LIF↑, 1,   LRIG1↑, 1,   pol-M1↑, 1,   M2 MC↓, 2,   pol-M2 MC↓, 1,   MCP1/CCL2↓, 9,   MCT1↓, 1,   MDSCs↓, 2,   MIP-1β↑, 1,   MIP2↓, 1,   mPGES-1↓, 2,   MyD88↓, 1,   MyD88↑, 1,   NAF1↓, 1,   Neut↑, 1,   NF-kB↓, 144,   NF-kB↑, 3,   NF-kB↝, 2,   p‑NF-kB↓, 2,   p‑NF-kB↑, 2,   NK cell↑, 8,   NLRP3↓, 4,   NLRP3↑, 1,   p50↓, 1,   p65↓, 1,   PD-1↓, 1,   PD-L1↓, 7,   PGE2↓, 17,   PSA↓, 7,   PSA∅, 1,   RAGE↓, 2,   SOCS-3↓, 1,   T-Cell↑, 1,   T-Cell↝, 1,   TCF↓, 3,   TCF↝, 1,   Th1 response↑, 2,   Th17↑, 1,   Th2↑, 1,   TLR4↓, 6,   TLR4↑, 1,   TLR4↝, 1,   TNF-α↓, 35,   TNF-α↑, 3,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   TRADD↑, 1,   TRAF1↓, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

IM↓, 1,   pH↝, 1,   e-pH↑, 1,   i-pH↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   ADRB2↓, 2,   AR↓, 13,   CYP17A1↓, 1,   CYP19↓, 2,   ER(estro)↓, 1,   ERα/ESR1↓, 1,   Estro↝, 1,   FGF21↓, 2,   GR↑, 1,   PPARα↓, 2,   PPARα↑, 1,   cl‑PPARα↓, 1,   PPARγ↓, 2,   PPARγ↑, 4,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 3,   BioAv↓, 53,   BioAv↑, 61,   BioAv↝, 9,   BioEnh↑, 5,   CBR1↓, 1,   chemoR↓, 1,   ChemoSen?, 1,   ChemoSen↓, 1,   ChemoSen↑, 164,   ChemoSen⇅, 1,   ChemoSen∅, 1,   CompStab?, 1,   CompStab↓, 3,   CompStab↑, 1,   CompStab↝, 1,   CYP1A1↓, 2,   CYP1A1↑, 3,   CYP1A2↓, 1,   CYP1A2↑, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 3,   DDS↑, 5,   Dose?, 5,   Dose↓, 4,   Dose↑, 3,   Dose⇅, 1,   Dose↝, 56,   Dose∅, 8,   DrugR↓, 2,   eff?, 1,   eff↓, 30,   eff↑, 99,   eff↝, 11,   eff∅, 3,   GSTZ1↓, 1,   Half-Life↓, 17,   Half-Life↑, 5,   Half-Life↝, 10,   Half-Life∅, 2,   MDR1↓, 12,   MRP1/ABCC1↓, 3,   NAT↓, 1,   P-gp/ABCB1↓, 20,   P-gp/ABCB1↝, 1,   P450↓, 4,   RadioS?, 2,   RadioS↑, 52,   selectivity?, 1,   selectivity↑, 68,   Synergy?, 1,   Synergy↓, 1,   Synergy↑, 105,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 2,   AFP↑, 1,   ALAT↓, 3,   ALP↓, 3,   AR↓, 13,   ascitic↓, 2,   AST↓, 2,   BloodF⇅, 1,   BRAF↓, 1,   BRCA1↓, 3,   BRCA1↑, 2,   BRCA1↝, 1,   CEC↝, 1,   CIT↓, 1,   CRP↓, 2,   CTC↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERα/ESR1↓, 1,   EZH2↓, 1,   Ferritin↓, 2,   FOXM1↓, 4,   HemoG↓, 1,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 11,   IL6↓, 34,   KRAS↓, 1,   LDH↓, 6,   LDH↑, 2,   Maspin↑, 1,   Myc↓, 5,   NOS2↓, 1,   PD-L1↓, 7,   Polyps↓, 1,   PSA↓, 7,   PSA∅, 1,   RAGE↓, 2,   TP53↑, 3,   TRIB3↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   AntiCan↓, 1,   AntiCan↑, 65,   AntiCan∅, 1,   antiNeop↑, 4,   AntiTum↑, 23,   cardioP↑, 10,   CardioT↓, 1,   CardioT↑, 2,   chemoP↑, 32,   chemoPv↑, 27,   ChemoSideEff↓, 5,   fatigue↓, 3,   fatigue∅, 1,   hepatoP↓, 1,   hepatoP↑, 9,   Mucositis↓, 1,   neuroP↑, 8,   OS↑, 21,   OS∅, 1,   Pain↓, 1,   PFS↑, 1,   Pin1↓, 2,   QoL↑, 8,   QoL∅, 1,   radioP↑, 11,   Remission↑, 3,   RenoP↑, 8,   Risk↓, 22,   Risk↑, 2,   Sleep↑, 1,   toxicity↓, 28,   toxicity↑, 4,   toxicity↝, 11,   toxicity∅, 1,   TumNum?, 1,   TumNum↓, 3,   TumVol↓, 27,   TumVol∅, 1,   TumW↓, 16,   TumW∅, 1,   Weight∅, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1,   AntiBio↑, 1,   AntiViral↑, 1,   Bacteria↓, 3,   GutMicro↑, 7,   GutMicro↝, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 14,  
Total Targets: 1036

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 7,   antiOx↑, 76,   Catalase↑, 26,   DPPH↓, 1,   GPx↑, 20,   GPx1↑, 3,   GPx4↑, 2,   GSH↑, 21,   GSR↑, 3,   GSSG↓, 1,   GSTs↑, 9,   H2O2↓, 2,   HDL↑, 1,   HNE↓, 1,   HO-1↑, 12,   i-Iron↓, 1,   Keap1↓, 1,   Keap1↑, 1,   lipid-P↓, 25,   MDA↓, 13,   MPO↓, 1,   NADH↓, 1,   NOX4↓, 1,   Nrf1↑, 2,   NRF2↑, 25,   RNS↓, 1,   ROS↓, 82,   ROS↑, 2,   ROS∅, 1,   SAM-e↑, 1,   selenoP↑, 1,   SOD↑, 28,   SOD1↑, 3,   SOD2↑, 1,   TAC↑, 3,   TBARS↓, 1,   TOS↓, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 4,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↓, 1,   OXPHOS↓, 1,   PGC-1α↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   5LO↓, 4,   5LO↝, 1,   ACSL4↓, 1,   ALAT?, 1,   ALAT↓, 5,   AMPK↓, 1,   AMPK↑, 3,   ATP↑, 1,   ATP↝, 1,   BHB↑, 1,   cytoP450↓, 1,   glucose↓, 5,   GlucoseCon↑, 1,   Glycolysis↑, 1,   GSK‐3β↓, 2,   HK2↑, 1,   LDHA↑, 1,   LDL↓, 5,   lipidLev↓, 1,   NAD↝, 1,   NADPH↑, 1,   PFKL↑, 1,   PFKM↑, 1,   PFKP↑, 1,   PKM2↑, 1,   SIRT1↑, 7,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 4,   ASC?, 1,   BAX↓, 3,   Bcl-2↑, 1,   Casp1↓, 1,   Casp3↓, 6,   Casp9↓, 3,   Cyt‑c↓, 2,   Ferroptosis↓, 2,   iNOS↓, 10,   iNOS↑, 1,   p38↓, 3,   Pyro?, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   Akt↑, 1,   AKT1↑, 1,   CREB↑, 1,   p‑CREB↑, 1,   ERK↓, 1,   ERK↑, 2,   JAK2↓, 1,   JNK↓, 1,   JNK↑, 1,   p‑JNK↓, 2,   p‑LIMK1↑, 1,   MAPK↓, 4,   MAPK↑, 2,   p‑MEK↑, 1,   mTOR↓, 1,   mTOR↑, 1,   PDGFR-BB↑, 1,   PI3K↓, 1,   PI3K↑, 2,   PKCδ↑, 1,   Sp1/3/4↓, 1,   STAT3↓, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 5,   ATF4↓, 1,   cMyc↓, 2,   HDAC↓, 1,   OCT4↓, 1,   other↓, 4,   other↑, 5,   other↝, 6,   SOX18↑, 1,   SOX9↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↓, 1,   CHOP/DDIT3↓, 1,   ER Stress↓, 3,   GRP78/BiP↓, 1,   HSP70/HSPA5↑, 2,   HSPs↑, 1,   PERK↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 4,   P53↓, 1,   PCNA↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cycD1/CCND1↓, 1,   GADD45A↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   BMPs↑, 1,   CD133↑, 1,   Diff↑, 1,   FGF↑, 2,   IGF-1↑, 1,   MSCs↑, 1,   neuroG↑, 2,   TumCP↓, 4,   tyrosinase↓, 1,   Wnt↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 8,   Ca+2↓, 2,   Ca+2↑, 1,   Ca+2↝, 2,   p‑Cofilin↑, 1,   COL1↑, 1,   COL2A1↑, 1,   EMT↓, 1,   FAK↑, 1,   ITGB1↑, 1,   p‑MLC2/MYL9↑, 1,   MMP13↓, 1,   MMP2↓, 2,   MMP2↑, 1,   MMP3↓, 1,   MMP9↓, 2,   MMP9↑, 2,   MYPT1 / PPP1R12A↑, 1,   p‑MYPT1 / PPP1R12A↑, 1,   N-cadherin↑, 1,   Rac1↑, 1,   Rho↓, 1,   ROCK1↑, 1,   serineP↓, 1,   Snail↑, 1,   TGF-β↓, 1,   TGF-β↑, 3,   TGF-β1↓, 1,   TIMP1↓, 1,   TIMP2↑, 1,   TumCI↓, 1,   TumCMig↓, 1,   Twist↑, 1,   uPA↓, 1,   Vim↑, 1,   α-SMA↑, 1,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 14,   angioG↑, 28,   angioG↝, 1,   CD31/PECAM-1↑, 1,   E-sel↓, 1,   eNOS↓, 2,   eNOS↑, 2,   Hif1a↓, 2,   Hif1a↑, 4,   NO↓, 8,   NO↑, 2,   VCAM-1↓, 2,   VEGF↓, 8,   VEGF↑, 12,   VEGFR2/KDR/Flk1↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 6,   CLDN5↑, 1,   GastroP↑, 1,   GLUT1↑, 1,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 2,   IBI↑, 1,   ketosis↑, 1,   MMP↑, 4,   MMP↝, 1,   MMP∅, 1,   OATPs↓, 1,   VGCC↑, 1,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD8+↑, 1,   COX1↓, 4,   COX2/PTGS2↓, 24,   CXCR4↓, 1,   ICAM-1↓, 2,   IFN-γ↓, 2,   IL1↓, 1,   IL10↓, 2,   IL10↑, 3,   IL12↓, 1,   IL17↓, 3,   IL18↓, 2,   IL1β↓, 12,   IL2↓, 1,   IL4↓, 1,   IL6↓, 16,   IL6↑, 1,   IL8↓, 1,   Imm↑, 6,   Imm⇅, 1,   Imm↝, 1,   Inflam↓, 90,   Inflam↑, 3,   IRF3↓, 2,   MCP1/CCL2↓, 1,   MyD88↓, 2,   NeuroI↓, 1,   NF-kB↓, 22,   NK cell↑, 2,   NLRP3↓, 3,   p65↓, 1,   PGE2↓, 9,   PGE2↑, 1,   Th1 response↓, 1,   Th2↑, 2,   TLR2↓, 3,   TLR4↓, 3,   TLR4∅, 1,   TNF-α↓, 20,   TNF-α↑, 1,   TRIF↓, 1,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   AChE↓, 7,   BChE↓, 1,   BDNF↑, 2,   GABA↑, 2,   GABA↝, 1,   MAOA↓, 1,   MAOB↓, 2,   NGF↑, 1,   TrkB↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 9,   BACE/β-secretase↓, 1,   tau↓, 3,   p‑tau↓, 3,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

Estro↓, 1,   PPARα↑, 1,   PPARγ↓, 1,   PPARγ↑, 2,   testos↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv?, 1,   BioAv↓, 30,   BioAv↑, 30,   BioAv⇅, 1,   BioAv↝, 15,   BioAv∅, 1,   BioEnh↑, 2,   CompStab↑, 2,   Dose↑, 1,   Dose⇅, 1,   Dose↝, 9,   Dose∅, 1,   eff↑, 8,   eff↝, 2,   GSTA1↑, 2,   Half-Life↑, 2,   Half-Life↝, 7,   Half-Life∅, 3,   P450↓, 1,   selectivity↑, 1,   Synergy↑, 7,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT?, 1,   ALAT↓, 5,   ALP↓, 2,   ascitic↓, 1,   AST↓, 7,   BloodF↑, 1,   BMD↑, 3,   BP↓, 2,   Calcium↑, 1,   creat↓, 1,   CRP↓, 4,   hs-CRP↓, 1,   IL6↓, 16,   IL6↑, 1,   LDH↓, 4,   Mag↑, 1,   NOS2↓, 1,   TC↓, 1,   Urea↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 3,   antiAll↑, 6,   AntiArt↑, 3,   AntiCan↓, 2,   AntiCan↑, 11,   AntiDiabetic↓, 1,   AntiDiabetic↑, 18,   AntiTum↓, 1,   AntiTum↑, 2,   Bone Healing↑, 1,   cardioP↑, 31,   cardioP⇅, 1,   chemoP↑, 3,   chemoPv↑, 3,   ChemoSideEff↓, 2,   cognitive↓, 1,   cognitive↑, 9,   diuretic↑, 1,   fatigue↓, 1,   hepatoP↓, 1,   hepatoP↑, 26,   memory↑, 12,   Mood↑, 1,   motorD↑, 2,   neuroP?, 1,   neuroP↓, 2,   neuroP↑, 45,   Obesity↓, 6,   OS↑, 1,   Pain↓, 3,   PDE4↓, 1,   radioP↑, 3,   RenoP↑, 5,   Risk↓, 2,   Sleep↑, 1,   Stress↓, 1,   Stroke↓, 3,   Stroke↝, 1,   toxicity↓, 33,   toxicity↑, 3,   toxicity↝, 8,   toxicity∅, 8,   Weight↓, 1,   Wound Healing↑, 5,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 8,   AntiFungal↑, 4,   AntiP↑, 4,   AntiViral↑, 8,   Bacteria↓, 17,   Bacteria↑, 1,   GutMicro↑, 12,   GutMicro↝, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 1,  
Total Targets: 369

Scientific Paper Hit Count for: angioG, angiogenesis
14 Magnetic Fields
14 Thymoquinone
12 itraconazole
11 Curcumin
11 Chrysin
11 Sulforaphane (mainly Broccoli)
9 Fisetin
9 Fucoidan
9 MCT, metronomic chemo
9 Resveratrol
9 Silymarin (Milk Thistle) silibinin
8 Artemisinin
8 Propolis -bee glue
8 Copper and Cu NanoParticles
8 Kaempferol
8 Quercetin
8 Luteolin
7 Ashwagandha(Withaferin A)
7 Betulinic acid
7 Cinnamon
7 Radiotherapy/Radiation
7 Eugenol
7 Nimbolide
6 Benzyl isothiocyanate
6 Phenethyl isothiocyanate
6 Capsaicin
5 Silver-NanoParticles
5 Apigenin (mainly Parsley)
5 Berberine
5 chitosan
5 Ellagic acid
5 EGCG (Epigallocatechin Gallate)
5 Formononetin
5 Gambogic Acid
5 Magnolol
5 Melatonin
5 Selenite (Sodium)
4 immunotherapy
4 Beta-Caryophyllene
4 Boswellia (frankincense)
4 Rosmarinic acid
4 Celastrol
4 D-limonene
4 Disulfiram
4 Isoliquiritigenin
4 Lycopene
3 Isothiocyanates
3 Carvacrol
3 Chlorogenic acid
3 Hydroxycinnamic-acid
3 Coenzyme Q10
3 Crocetin
3 Dichloroacetate
3 Emodin
3 Ferulic acid
3 Gallic acid
3 phytic acid, Inositol hexakisphosphate
3 Ivermectin
3 Juglone
3 mebendazole
3 methylseleninic acid
3 Piperlongumine
3 Spirulina(Arthrospira/Limnospira)
3 tetrathiomolybdate
2 3-bromopyruvate
2 chemodynamic therapy
2 Allyl isothiocyanate
2 Allicin (mainly Garlic)
2 Alpha-Lipoic-Acid
2 Chemotherapy
2 beta-glucans
2 Baicalein
2 Boron
2 Caffeic acid
2 Carnosic acid
2 chaetocin
2 Carica papaya leaf extract
2 Cucurbitacin
2 Deguelin
2 Diclofenac
2 Dipyridamole
2 Dandelion Root
2 Ginkgo biloba-EGb 761
2 Flaxseed/Linseed
2 Garcinol
2 Ginkgolide B
2 Helleborus niger extracts – Christmas Rose
2 Honokiol
2 HydroxyTyrosol
2 isoflavones
2 Isovitexin
2 Licochalcone A
2 SDG/lignans
2 Linalool
2 Modified Citrus Pectin
2 Mangiferin
2 Mistletoe/Viscum album Extracts
2 Mushroom Lion’s Mane, Hericium erinaceus
2 Naringin
2 Phycocyanin
2 Piperine
2 Propranolol
2 Pterostilbene
2 α-Santalol/Sandalwood oil
2 Selenium
2 Selenium NanoParticles
2 Ursolic acid
2 Zyflamend
1 Annona atemoya Seed Extract
1 Auranofin
1 Astragalus
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Andrographis
1 Anethole/trans-Anethole
1 Aspirin
1 Ascorbyl Palmitate
1 Atorvastatin
1 Aloe anthraquinones
1 Biochanin A
1 Bufalin/Huachansu
1 borneol
1 Beetroot
1 Black turtle bean
1 urea
1 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
1 Caffeic Acid Phenethyl Ester (CAPE)
1 Sorafenib (brand name Nexavar)
1 Carnosine
1 Celecoxib
1 Centella asiatica / Gotu kola → asiaticoside
1 Chocolate
1 Metformin
1 Cimetidine
1 Citric Acid
1 Vitamin E
1 diet FMD Fasting Mimicking Diet
1 diet Ketogenic
1 Diindolylmethane
1 Zinc
1 Echinacea
1 Electrical Pulses
1 flavonoids
1 olaparib/LYNPARZA
1 Ginkgo biloba
1 Genistein (soy isoflavone)
1 Geraniol
1 Ginger/6-Shogaol/Gingerol
1 Ginkgetin
1 Gossypol/AT-101
1 Hydrogen Gas
1 hydrogen sulfide
1 Hibiscus sabdariffa
1 Hops (Humulus lupulus)
1 Isorhamnetin
1 isoorientin
1 Vitexin
1 low dose naltrexone
1 Docetaxel
1 Matrine
1 Sulindac
1 Paclitaxel/Taxol
1 Methyl Jasmonate
1 vp16, etoposide
1 Magnetic Field Rotating
1 Lemon Balm/Melissa officinalis
1 Neem
1 Oroxylin-A
1 Oleuropein
1 Oleocanthal
1 Marjoram (Origanum majorana)
1 Oregano
1 Phenylbutyrate
1 Purple Corn / Purple Maize
1 Plumbagin
1 Pomi-T
1 Psoralidin
1 Ramucirumab (CYRAMZA)
1 Rutin
1 buckwheat sprouts
1 Salvia officinalis
1 salinomycin
1 Sesamin
1 Shikonin
1 Theobromine
1 Aflavin-3,3′-digallate
1 Thymol-Thymus vulgaris
1 Urolithin
1 Usnic acid
1 Vitamin C (Ascorbic Acid)
1 Vitamin D3
1 Walnut
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:447  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page